000 01542 a2200373 4500
005 20250518052115.0
264 0 _c20200116
008 202001s 0 0 eng d
022 _a1744-2818
024 7 _a10.1080/13506129.2019.1582520
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCárdenas-Soto, Karla
245 0 0 _aQuality of life assessment after 6 months of initiating treatment with tafamidis in patients with non-Val30Met mutations.
_h[electronic resource]
260 _bAmyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
_c
300 _a57-58 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAmyloid Neuropathies, Familial
_xdrug therapy
650 0 4 _aBenzoxazoles
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMutation
650 0 4 _aPrealbumin
_xgenetics
650 0 4 _aQuality of Life
700 1 _aTorres-Octavo, Benjamín
700 1 _aMendoza-Tejeda, Claudia
700 1 _aFueyo-Rodríguez, Omar
700 1 _aDomínguez-Rico, Carolina
700 1 _aGonzalez-Duarte, Alejandra
773 0 _tAmyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
_gvol. 26
_gno. sup1
_gp. 57-58
856 4 0 _uhttps://doi.org/10.1080/13506129.2019.1582520
_zAvailable from publisher's website
999 _c29937835
_d29937835